clotrimazole and cytochrome c-t

clotrimazole has been researched along with cytochrome c-t in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anzellotti, A; Rieber, M; Sánchez-Delgado, RA; Strasberg Rieber, M	1
Bhaskar, P; Chandel, NS; Coy, PE; Gottlob, K; Hay, N; Majewski, N; Nogueira, V; Robey, RB; Skeen, JE; Thompson, CB	1

Other Studies

2 other study(ies) available for clotrimazole and cytochrome c-t

Article	Year
Tumor apoptosis induced by ruthenium(II)-ketoconazole is enhanced in nonsusceptible carcinoma by monoclonal antibody to EGF receptor. International journal of cancer, 2004, Nov-10, Volume: 112, Issue:3 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Caspase 3; Caspases; Cisplatin; Clotrimazole; Combined Modality Therapy; Cytochromes c; Drug Synergism; Enzyme Activation; ErbB Receptors; Humans; Ketoconazole; Membrane Proteins; Mitochondria; Neoplasms; Poly(ADP-ribose) Polymerases; Ruthenium Compounds; Spheroids, Cellular; Superoxide Dismutase; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2004
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Molecular cell, 2004, Dec-03, Volume: 16, Issue:5 Topics: Animals; Apoptosis; Binding, Competitive; Cell Line; Cell Proliferation; Cells, Cultured; Clotrimazole; Cytochromes c; Dose-Response Relationship, Drug; Fibroblasts; Gene Transfer Techniques; Growth Inhibitors; Growth Substances; Hexokinase; Immunoblotting; In Situ Nick-End Labeling; Intracellular Membranes; Membrane Potentials; Mice; Microscopy, Fluorescence; Mitochondria; Phosphocreatine; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Thapsigargin; Time Factors; Ultraviolet Rays	2004

Article

Year

Tumor apoptosis induced by ruthenium(II)-ketoconazole is enhanced in nonsusceptible carcinoma by monoclonal antibody to EGF receptor.

International journal of cancer, 2004, Nov-10, Volume: 112, Issue:3

Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Caspase 3; Caspases; Cisplatin; Clotrimazole; Combined Modality Therapy; Cytochromes c; Drug Synergism; Enzyme Activation; ErbB Receptors; Humans; Ketoconazole; Membrane Proteins; Mitochondria; Neoplasms; Poly(ADP-ribose) Polymerases; Ruthenium Compounds; Spheroids, Cellular; Superoxide Dismutase; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2004

Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.

Molecular cell, 2004, Dec-03, Volume: 16, Issue:5

Topics: Animals; Apoptosis; Binding, Competitive; Cell Line; Cell Proliferation; Cells, Cultured; Clotrimazole; Cytochromes c; Dose-Response Relationship, Drug; Fibroblasts; Gene Transfer Techniques; Growth Inhibitors; Growth Substances; Hexokinase; Immunoblotting; In Situ Nick-End Labeling; Intracellular Membranes; Membrane Potentials; Mice; Microscopy, Fluorescence; Mitochondria; Phosphocreatine; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Thapsigargin; Time Factors; Ultraviolet Rays

2004